Trials / Unknown
UnknownNCT00961363
Effect of Sitagliptin in Impaired Glucose Tolerance
The Effect of Sitagliptin on Postprandial Glycemia and Endothelial Function in Chinese Subjects With Impaired Glucose Tolerance
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the safety and efficacy of sitagliptin 100 mg every day (q.d.) in improving hyperglycemia and endothelial dysfunction in subjects with impaired glucose tolerance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sitagliptin | sitagliptin 100 mg per day |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2011-06-01
- First posted
- 2009-08-18
- Last updated
- 2010-03-22
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00961363. Inclusion in this directory is not an endorsement.